Medical Pharmacology: Opioid Analgesic Practice
Questions
Click on the correct answer.
CNS effect(s) associated with pentazocine, a partial agonist/antagonist:
- Analgesia
- Respiratory depression
- Both
- Neither
Effect(s) associated with higher doses of pentazocine (60-90 mg):
- Psychotomimetic effects
- Dysphoria
- Both
- Neither
Pentazocine, a partial agonist/antagonist, is effective in reversing morphine-induced respiratory depression.
- True
- False
Pentazocine (Talwin) therapeutic use(s):
- Management of moderate to severe pain
- Anastasia supplement
- Both
- Neither
Nalbuphene:
- Related structurally to oxymorphone and naloxone
- kappa-type opioid receptor agonist
- Mu-type of opioid agonist
- A & B
- A & C
- A, B & C
Nalbuphene (Nubain) is clinically used for pain relief.
- True
- False
Butorphanol (Stadol) exhibits a comparable action compared to nalbuphene and pentazocine.
- True
- False
Appropriate clinical use for butorphanol: relief of acute pain-as may occur in the postoperative setting.
- True
- False
Major side effect(s) associated with butorphanol:
- Drowsiness
- Sweating
- Nausea
- All of the above
Buprenorphine:
- Analgesic agent
- Oral formulation (US) and in fixed dose combination with no locks on: limited to management of opioid dependence
- Both
- Neither
|
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above. |
|
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
 |